The Use of Triamcinolone Injection in Treatment of Refractory Benign Esophageal Stricture in Children
1 other identifier
interventional
20
0 countries
N/A
Brief Summary
To evaluate the efficacy of Intra-lesional triamcinolone injection in the management of refractory benign esophageal Stricture in children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
Started Dec 2020
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 16, 2020
CompletedFirst Posted
Study publicly available on registry
August 24, 2020
CompletedStudy Start
First participant enrolled
December 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2022
CompletedOctober 27, 2020
August 1, 2020
10 months
August 16, 2020
October 25, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
number of patients show improvement in dysphagia scale after five session of triamcinolone injection
number of patients show improvement in dysphagia scale after five session of triamcinolone injection
2years
Secondary Outcomes (1)
the number of patients who will show complete relieve of dysphagia after five sessions of triamcinolone injection
2years
Study Arms (1)
The use of Triamcinolone Injection
OTHERTriamcinolone acetate (40 mg/mL)
Interventions
Triamcinolone Injection in treatment of refractory benign Esophageal Stricture with endoscopic dilatation
Eligibility Criteria
You may qualify if:
- All patients admitted to Assiut University Children Hospital with:
- refractory benign esophageal stricture(inability to successfully remediate the anatomic problem to a diameter of at least 14 mm over five sessions at two-week interval)
- inability to maintain a satisfactory luminal diameter for four weeks once the target diameter of 14 mm has been achieved
You may not qualify if:
- Pharyngeal stenosis precluding endoscopic examination and dilatation
- tracheo-esophageal fistula,
- gastric cicatrization that precluded safe placement of aguidewire
- any patient who was unfit for general anesthesia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (9)
Morikawa N, Honna T, Kuroda T, Watanabe K, Tanaka H, Takayasu H, Fujino A, Tanemura H, Matsukubo M. High dose intravenous methylprednisolone resolves esophageal stricture resistant to balloon dilatation with intralesional injection of dexamethasone. Pediatr Surg Int. 2008 Oct;24(10):1161-4. doi: 10.1007/s00383-008-2224-7.
PMID: 18704454BACKGROUNDContini S, Scarpignato C. Caustic injury of the upper gastrointestinal tract: a comprehensive review. World J Gastroenterol. 2013 Jul 7;19(25):3918-30. doi: 10.3748/wjg.v19.i25.3918.
PMID: 23840136BACKGROUNDMowry JB, Spyker DA, Cantilena LR Jr, McMillan N, Ford M. 2013 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 31st Annual Report. Clin Toxicol (Phila). 2014 Dec;52(10):1032-283. doi: 10.3109/15563650.2014.987397.
PMID: 25559822BACKGROUNDPark KS. Evaluation and management of caustic injuries from ingestion of Acid or alkaline substances. Clin Endosc. 2014 Jul;47(4):301-7. doi: 10.5946/ce.2014.47.4.301. Epub 2014 Jul 28.
PMID: 25133115BACKGROUNDKochman ML, McClave SA, Boyce HW. The refractory and the recurrent esophageal stricture: a definition. Gastrointest Endosc. 2005 Sep;62(3):474-5. doi: 10.1016/j.gie.2005.04.050. No abstract available.
PMID: 16111985BACKGROUNDBerger M, Ure B, Lacher M. Mitomycin C in the therapy of recurrent esophageal strictures: hype or hope? Eur J Pediatr Surg. 2012 Apr;22(2):109-16. doi: 10.1055/s-0032-1311695. Epub 2012 Apr 19.
PMID: 22517516BACKGROUNDRavich WJ. Endoscopic Management of Benign Esophageal Strictures. Curr Gastroenterol Rep. 2017 Aug 24;19(10):50. doi: 10.1007/s11894-017-0591-8.
PMID: 28840483BACKGROUNDNagaich N, Nijhawan S, Katiyar P, Sharma R, Rathore M. Mitomycin-C: 'a ray of hope' in refractory corrosive esophageal strictures. Dis Esophagus. 2014 Apr;27(3):203-5. doi: 10.1111/dote.12092. Epub 2013 Jun 24.
PMID: 23796367BACKGROUNDPoddar U, Thapa BR. Benign esophageal strictures in infants and children: results of Savary-Gilliard bougie dilation in 107 Indian children. Gastrointest Endosc. 2001 Oct;54(4):480-4. doi: 10.1067/mge.2001.118253.
PMID: 11577311BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Nagla Abou Faddan, Professor
Assiut University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assiut university children hospital, assistant lecturer ,gastroentrologyand hepatology and endoscopy unit.
Study Record Dates
First Submitted
August 16, 2020
First Posted
August 24, 2020
Study Start
December 1, 2020
Primary Completion
October 1, 2021
Study Completion
March 1, 2022
Last Updated
October 27, 2020
Record last verified: 2020-08